查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1790235

感染控制市场规模、份额和趋势分析报告：按类型、最终用途、地区和细分市场预测，2025 年至 2030 年

Infection Control Market Size, Share & Trends Analysis Report By Type, By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

感染控制市场概况

2024 年全球感染控制市场价值估计为 523.8 亿美元，预计到 2030 年将达到 742.1 亿美元，2025 年至 2030 年期间的复合年增长率为 6.1%。该市场主要受需要预防感染的外科手术和临床程序增加的推动。

感染控制技术的进步显着提高了医疗机构的感染预防和控制能力。自动消毒系统、紫外线技术、抗菌表面涂层和先进的空气过滤系统等创新技术已被证明可有效降低高达 30% 的医院感染 (HAI)，预计将促进市场成长。灭菌服务外包的增加以及先进灭菌解决方案的采用进一步促进了感染控制市场的成长。关键成长要素之一是政府加强实施先进的感染预防措施。政府机构越来越多地参与发布指南，以提高全球意识并采取有效的预防措施，预计这些措施将在整个预测期内促进市场成长。例如，世界卫生组织 (WHO) 发布了医疗保健领域流行病和流行性急性呼吸道疾病预防控制指南。这些指南涵盖了从手部卫生和个人防护工具使用等标准预防措施到消毒和灭菌指南。

根据美国国家医学图书馆2024年5月发表的一篇论文，急性呼吸道感染疾病（ARI）是全球重大的健康负担，每年造成约425万人死亡。这些感染疾病每年导致数百万人次门诊就诊，尤其影响老年人、幼儿以及气喘和心臟病等慢性疾病患者等高风险族群。

肺炎等感染疾病以及血流感染、尿道感染、手术部位感染和 MRSA 等感染占医院获得性感染的大多数。其他主要的医院相关感染疾病(HAI) 包括导管相关尿道感染、人工呼吸器相关性肺炎和导管相关血流感染疾病。 HAI 严重影响全球死亡率，因为它们影响患者的康復。根据 2023 年 4 月 NIH 的一篇报导，HAI 是医院中最常见的不良事件，导致严重的健康风险、发病率和死亡率增加，并增加患者、家庭和医疗保健系统的成本。 HAI 影响美国约 3.2% 的住院患者和欧盟 6.5% 的住院患者，预计全球盛行率将持续上升。这导致对有效的感染预防和控制解决方案的需求增加。

根据世界卫生组织《医院内获得性感染预防实用指南》，手术感染疾病导致的住院时间增加约8天。预计住院时间的延长将显着增加住院期间的总费用，从而增加了采取感染预防措施的临床紧迫性。由于过度使用资源来治疗获得性感染疾病，延长住院时间对医院和医疗保健支付者来说也是不经济的。这些额外费用主要来自药物使用量的增加、额外的诊断检测和实验室设备的增加，造成资源分配的不平衡。

目录

第一章调查方法与范围

第二章执行摘要

第三章感染控制市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 感染控制市场分析工具
    • 产业分析—波特五力分析
    • PESTEL分析
  • 感染控制市场：通路分析

第四章感染控制市场：按类型估计和趋势分析

  • 类型细分仪表板
  • 感染控制市场：类型变化分析
  • 全球感染控制市场规模及趋势分析（按类型）（2018-2030）
  • 装置
    • 消毒剂
    • 消毒器
    • 其他的
  • 服务
    • 合约节育手术
    • 传染性废弃物的处理
  • 耗材
    • 传染性废弃物的处理
    • 消毒剂
    • 无菌耗材
    • 个人防护设备
    • 其他的

第五章感染控制市场：依最终用途的估计和趋势分析

  • 最终用途细分仪表板
  • 感染控制市场：最终用途变异分析
  • 全球感染控制市场规模与趋势分析（依最终用途，2018-2030 年）
  • 医院
  • 医疗设备公司
  • 临床实验室
  • 製药实验室
  • 其他的

第六章感染控制市场：按地区估计和趋势分析

  • 区域市场仪表板
  • 2024 年及 2030 年区域市场占有率分析
  • 感染控制市场（按地区）: 关键要点
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争态势

  • 主要市场参与企业的近期趋势和影响分析
  • 公司/竞争对手分类
  • 供应商格局
    • 2024年主要企业热图分析
  • 公司简介
    • 3M
    • Belimed AG
    • O& M Halyard or its affiliates.
    • GETINGE AB（publ）Corporate
    • ASP
    • MATACHANA
    • Sterigenics US, LLC-A Sotera Health company
    • MMM Group
    • Medivators Inc.
    • STERIS.
    • Midmark Corporation
    • W& H
Product Code: GVR-1-68038-822-0

Infection Control Market Summary

The global infection control market size was estimated at USD 52.38 billion in 2024, and is projected to reach USD 74.21 billion by 2030, growing at a CAGR of 6.1% from 2025 to 2030. The market is primarily driven by an increasing number of surgical & clinical procedures that require infection prevention.

Technological advancements in infection control have significantly enhanced the ability of healthcare providers to prevent and manage infections. Innovations such as automated disinfection systems, UV light technology, antimicrobial surface coatings, and advanced air filtration systems have demonstrated efficacy in reducing HAIs by up to 30% and is expected to contribute to the market growth. An increase in outsourcing sterilization services and the introduction of advanced sterilizing solutions are further contributing to the growth of the market for infection control. One of the important growth drivers is the increasing number of government initiatives to ensure highly intensive infection prevention. Government organizations are increasingly involved in issuing guidelines to promote awareness and efficient prevention measures globally, which is expected to contribute to market growth throughout the forecast period. For instance, the World Health Organization (WHO) has issued guidelines for preventing and controlling pandemic- and epidemic-prone acute respiratory diseases in healthcare. The guidelines range from standard precautions such as hand hygiene and usage of personal protective equipment to guidelines for disinfection and sterilization.

According to the article published by the National Library of Medicine in May 2024, Acute respiratory infections (ARIs) are a major global health burden, leading to around 4.25 million deaths annually. These infections lead to millions of outpatient visits each year, particularly affecting high-risk groups such as the elderly, young children, and individuals with chronic conditions such as asthma or heart disease.

Diseases such as pneumonia and infections such as bloodstream, urinary tract, surgical site, and MRSA constitute most hospital-acquired infections. Other major healthcare-associated infections (HAIs) include catheter-associated urinary tract infections, ventilator-associated pneumonia, and catheter-related bloodstream. One of the utmost concerns for the market is HAIs, which affect patient recovery; thereby, mortality rates are being significantly impacted globally. According to an article by NIH in April 2023, HAIs are the most common adverse effects in hospitals, leading to serious health risks, increased morbidity and mortality, and higher costs for patients, families, and healthcare systems. HAIs affect about 3.2% of hospitalized patients in the U.S. and 6.5% in the EU, with global prevalence expected to be even higher. This facilitates the need for effective infection prevention and control solutions.

According to a practical guide published by the WHO on preventing hospital-acquired infections, the increase in hospitalization duration with surgical infections was approximately eight days. These prolonged stays are predicted to significantly contribute to the overall costs incurred during the hospitalization period, thus, raising the clinical urgency for adopting infection prevention measures. It is presumed that prolonged hospital stay is also not economical for the hospitals and healthcare payers due to excessive usage of resources to treat the acquired infection. These additional costs are majorly generated through increased usage of drugs, additional diagnostic studies, and laboratory equipment, creating a resource allocation imbalance.

Global Infection Control Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2018 to 2030. For the purpose of this report, Grand View Research has segmented the global infection control market on the basis of type, end use, and region:

  • Type Outlook (Revenue, USD Billion, 2018 - 2030)
  • Equipment
    • Disinfectors
    • Washers
    • Flushes
    • Endoscope Reprocessors
    • Sterilization Equipment
    • Heat Sterilization Equipment
    • Low Temperature Sterilization Equipment
    • Radiation Sterilization Equipment
    • Filtration Sterilization Equipment
    • Liquid Sterilization Equipment
    • Others
  • Services
    • Contract Sterilization
    • Ethylene Oxide Sterilization
    • E-beam Sterilization
    • Gamma Sterilization
    • Others
    • Infectious Waste Disposal
  • Consumables
    • Infectious Waste Disposal
    • Disinfectants
    • Sterilization Consumables
    • Safety enhanced medical devices
    • Personal Protective Equipment
    • Others
  • End Use Outlook (Revenue, USD Billion, 2018 - 2030)
  • Hospitals
  • Medical Device Companies
  • Clinical Laboratories
  • Pharmaceutical Laboratories
  • Others
  • Regional Outlook (Revenue, USD Billion, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. End Use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. End use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Infection Control Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Infection Control Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
  • 3.4. Infection Control Market: Pipeline Analysis

Chapter 4. Infection Control Market: Type Estimates & Trend Analysis

  • 4.1. Type Segment Dashboard
  • 4.2. Infection Control Market: Type Movement Analysis
  • 4.3. Global Infection Control Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Equipment
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Disinfectors
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.2. Washers
        • 4.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.3. Flushes
        • 4.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.4. Endoscope Reprocessors
        • 4.4.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Sterilization Equipment
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.2. Heat sterilization equipment
        • 4.4.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.3. Low Temperature Sterilization Equipment
        • 4.4.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.4. Radiation Sterilization Equipment
        • 4.4.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.5. Filtration Sterilization Equipment
        • 4.4.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.6. Liquid Sterilization Equipment
        • 4.4.3.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Others
      • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Services
    • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.2. Contract Sterilization
      • 4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.2.2. Ethylene Oxide Sterilization
        • 4.5.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.2.3. E-beam Sterilization
        • 4.5.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.2.4. Gamma Sterilization
        • 4.5.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.2.5. Others
        • 4.5.2.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.3. Infectious Waste Disposal
  • 4.6. Consumables
    • 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.2. Infectious Waste Disposal
      • 4.6.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.3. Disinfectants
      • 4.6.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.4. Sterilization Consumables
      • 4.6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.5. Personal Protective Equipment
      • 4.6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.6. Others
      • 4.6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Infection Control Market: End Use Estimates & Trend Analysis

  • 5.1. End Use Segment Dashboard
  • 5.2. Infection Control Market: End Use Movement Analysis
  • 5.3. Global Infection Control Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 5.4. Hospitals
    • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Medical Device Companies
    • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Clinical Laboratories
    • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Pharmaceutical Laboratories
    • 5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. Others
    • 5.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Infection Control Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Dashboard
  • 6.2. Regional Market Share Analysis, 2024 & 2030
  • 6.3. Infection Control Market by Region: Key Takeaways
  • 6.4. North America
    • 6.4.1. U.S.
      • 6.4.1.1. Key country dynamics
      • 6.4.1.2. Regulatory framework/ reimbursement structure
      • 6.4.1.3. Competitive scenario
      • 6.4.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Canada
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework/ reimbursement structure
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Mexico
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework/ reimbursement structure
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. UK
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Germany
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. France
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.4. Italy
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.5. Spain
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.6. Norway
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.7. Sweden
      • 6.5.7.1. Key country dynamics
      • 6.5.7.2. Regulatory framework/ reimbursement structure
      • 6.5.7.3. Competitive scenario
      • 6.5.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.8. Denmark
      • 6.5.8.1. Key country dynamics
      • 6.5.8.2. Regulatory framework/ reimbursement structure
      • 6.5.8.3. Competitive scenario
      • 6.5.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Japan
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. China
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.3. India
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.4. Australia
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework/ reimbursement structure
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.5. South Korea
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework/ reimbursement structure
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.6. Thailand
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework/ reimbursement structure
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Brazil
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. Argentina
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. MEA
    • 6.8.1. South Africa
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework/ reimbursement structure
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.2. Saudi Arabia
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework/ reimbursement structure
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.3. UAE
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Regulatory framework/ reimbursement structure
      • 6.8.3.3. Competitive scenario
      • 6.8.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.4. Kuwait
      • 6.8.4.1. Key country dynamics
      • 6.8.4.2. Regulatory framework/ reimbursement structure
      • 6.8.4.3. Competitive scenario
      • 6.8.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. Key company heat map analysis, 2024
  • 7.4. Company Profiles
    • 7.4.1. 3M
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Belimed AG
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. O&M Halyard or its affiliates.
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. GETINGE AB (publ) Corporate
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. ASP
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. MATACHANA
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. Sterigenics U.S., LLC - A Sotera Health company
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Product benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. MMM Group
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Product benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. Medivators Inc.
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Product benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. STERIS.
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Product benchmarking
      • 7.4.10.4. Strategic initiatives
    • 7.4.11. Midmark Corporation.
      • 7.4.11.1. Company overview
      • 7.4.11.2. Financial performance
      • 7.4.11.3. Product benchmarking
      • 7.4.11.4. Strategic initiatives
    • 7.4.12. W&H
      • 7.4.12.1. Company overview
      • 7.4.12.2. Financial performance
      • 7.4.12.3. Product benchmarking
      • 7.4.12.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global infection control market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global infection control market, by type, 2018 - 2030 (USD Million)
  • Table 4 Global infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 5 North America infection control market, by country, 2018 - 2030 (USD Million)
  • Table 6 North America infection control market, by type, 2018 - 2030 (USD Million)
  • Table 7 North America infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 8 U.S. infection control market, by type, 2018 - 2030 (USD Million)
  • Table 9 U.S. infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 10 Canada infection control market, by type, 2018 - 2030 (USD Million)
  • Table 11 Canada infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 12 Mexico infection control market, by type, 2018 - 2030 (USD Million)
  • Table 13 Mexico infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 14 Europe infection control market, by country, 2018 - 2030 (USD Million)
  • Table 15 Europe infection control market, by type, 2018 - 2030 (USD Million)
  • Table 16 Europe infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 17 Germany infection control market, by type, 2018 - 2030 (USD Million)
  • Table 18 Germany infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 19 UK infection control market, by type, 2018 - 2030 (USD Million)
  • Table 20 UK infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 21 France infection control market, by type, 2018 - 2030 (USD Million)
  • Table 22 France infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 23 Italy infection control market, by type, 2018 - 2030 (USD Million)
  • Table 24 Italy infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 25 Spain infection control market, by type, 2018 - 2030 (USD Million)
  • Table 26 Spain infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 27 Denmark infection control market, by type, 2018 - 2030 (USD Million)
  • Table 28 Denmark infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 29 Sweden infection control market, by type, 2018 - 2030 (USD Million)
  • Table 30 Sweden infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 31 Norway infection control market, by type, 2018 - 2030 (USD Million)
  • Table 32 Norway infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific infection control market, by country, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific infection control market, by type, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 36 China infection control market, by type, 2018 - 2030 (USD Million)
  • Table 37 China infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 38 Japan infection control market, by type, 2018 - 2030 (USD Million)
  • Table 39 Japan infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 40 India infection control market, by type, 2018 - 2030 (USD Million)
  • Table 41 India infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 42 South Korea infection control market, by type, 2018 - 2030 (USD Million)
  • Table 43 Australia infection control market, by type, 2018 - 2030 (USD Million)
  • Table 44 Thailand infection control market, by type, 2018 - 2030 (USD Million)
  • Table 45 Thailand infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 46 Latin America infection control market, by country, 2018 - 2030 (USD Million)
  • Table 47 Latin America infection control market, by type, 2018 - 2030 (USD Million)
  • Table 48 Latin America infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 49 Brazil infection control market, by type, 2018 - 2030 (USD Million)
  • Table 50 Brazil infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 51 Argentina infection control market, by type, 2018 - 2030 (USD Million)
  • Table 52 Argentina infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 53 MEA infection control market, by country, 2018 - 2030 (USD Million)
  • Table 54 MEA infection control market, by type, 2018 - 2030 (USD Million)
  • Table 55 MEA infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 56 South Africa infection control market, by type, 2018 - 2030 (USD Million)
  • Table 57 South Africa infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia infection control market, by type, 2018 - 2030 (USD Million)
  • Table 59 Saudi Arabia infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 60 UAE infection control market, by type, 2018 - 2030 (USD Million)
  • Table 61 UAE infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 62 Kuwait infection control market, by type, 2018 - 2030 (USD Million)
  • Table 63 Kuwait infection control market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Infection control market: market outlook
  • Fig. 10 Infection control market competitive insights
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration and growth prospect mapping
  • Fig. 14 Industry value chain analysis
  • Fig. 15 Infection control market driver impact
  • Fig. 16 Infection control market restraint impact
  • Fig. 17 Infection control market strategic initiatives analysis
  • Fig. 18 Infection control market: Type movement analysis
  • Fig. 19 Infection control market: Type outlook and key takeaways
  • Fig. 20 Equipment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Disinfectors market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Washers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Flushes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Endoscope reprocessors market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Sterilization equipment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Heat sterilization equipment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Low temperature sterilization equipment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Radiation sterilization equipment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Filtration sterilization equipment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Liquid sterilization equipment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Contract sterilization market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Ethylene oxide Sterilization market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 E-beam sterilization market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Gamma sterilization market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Infectious waste Disposal market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Consumables market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Infectious waste disposal market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Disinfectants market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Safety enhanced medical devices market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Sterilization consumables market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Personal protective equipment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Infection control market: End use movement Analysis
  • Fig. 47 Infection control market: End use outlook and key takeaways
  • Fig. 48 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Medical device companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Clinical laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Pharmaceutical laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Global infection control market: Regional movement analysis
  • Fig. 54 Global infection control market: Regional outlook and key takeaways
  • Fig. 55 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)